India, Russia and Iran have authorized nasal vaccines. And while none of those have yet been proven to stop Covid transmission, officials say the U.S. could find itself at a global disadvantage, particularly if a deadlier variant emerges.
Intranasal vaccines vaccines that are variant-resistant those are critical tools to have in the toolbox for protecting Americans, not just for Covid but also for future pandemics and also for future biosecurity threats, Ashish Jha, the administrations Covid-19 response coordinator, told POLITICO.
Researchers working on nasal vaccines are hopeful that they could stop virus transmission by generating immunity against it in the nose and other parts of the upper respiratory system where the coronavirus enters the body. If that bears out in clinical trials, nasal vaccines would be superior to existing mRNA vaccines, which prevent severe disease but dont stop transmission.
Officials at the National Institute of Allergy and Infectious Diseases are attuned to the danger of failing to develop such a nasal vaccine since it would protect people in case of a more contagious and deadlier coronavirus variant, said Karin Bok, the acting deputy director for pandemic preparedness and emergency response at the agencys Vaccine Research Center.
The center has mapped the nasal and oral Covid vaccines in development in the U.S. and abroad. It is also testing nasal versions of the Moderna vaccine and two other types of injectable Covid-19 vaccines in monkeys, Bok said. But that probably wont lead to a nasal Covid vaccine being approved in the U.S. anytime soon because funding for clinical trials and production is lacking.
Bok and Jha say the cost is high. If China were to develop a nasal vaccine capable of stopping Covid transmission, that could turn the tables on the current pandemic trajectory, which has the U.S. emerging and much of China stuck in lockdown.
Even though India, Iran, China and Russia havent proved their non-injectable vaccines stop transmission, the potential is there, experts said.
Countries where transmission is reduced are going to be healthier, are going to have stronger economies. And the U.S. needs to catch up, said Marty Moore, the founder and chief scientific officer of Meissa Vaccines, a small biotech company thats trying to develop a nasal vaccine in the U.S.
Many scientists believe the nose could hold the secret to stopping coronavirus transmission, but theres no consensus yet on whether nasal vaccines could be more effective than injectable ones, as evidence from clinical trials is necessary to prove it.
Disagreement in Congress about how to pay for additional aid or whether its needed, as well as disinterest from major drugmakers in spending their own money on something that may not be very profitable, could mean a foreign rival gets an advantage.
Writing in Science Immunology in July, Eric Topol, a professor of molecular medicine at Scripps Research, and Akiko Iwasaki, an immunobiology professor at Yale, endorsed the potential of a nasal vaccine to stop coronavirus transmission. Breaking the chain of transmission at the individual and population level will put us in a far better position to achieve containment of the virus, they wrote, adding that the prospect of achieving this with nasal vaccines is high.
They called for U.S. government support in developing Operation Warp Speed 2.0, modeled on the initiative that created the first Covid-19 vaccines in record time. The Biden administration is working on that, but funding woes and pandemic fatigue have hampered its efforts.
Beyond effectiveness, a nasal vaccine could appeal to people who are squeamish about needles and to parents of young children who have mostly declined to get their kids inoculated. As of early October, only 9 percent of children ages 6 months to 5 years have gotten the shots, which were authorized by the FDA in June.
Outside of the government-funded research cited by Bok, two Washington University School of Medicine professors, David T. Curiel, a radiation oncologist, and Michael S. Diamond, a molecular microbiologist, invented the nasal vaccine authorized in India.
Curiel and Diamond told POLITICO they created it with the needs of the developing world in mind, given the lack of ultracold freezers needed to store mRNA vaccines. The two scientists licensed their vaccine to the Indian drugmaker Bharat Biotech, which tested it in clinical trials partially financed by the Indian government. They have also tried to solicit interest from large U.S. pharmaceutical companies about it and there was not as much excitement as we would have thought, Diamond said.
Their vaccine, named iNCOVACC in India, is based on an adenovirus that delivers the coronavirus spike protein.
Bharat Biotech tested it both as a primary vaccination series and as a booster for people who were vaccinated with injectable Covid shots available in India. The company said the clinical trials had successful results and that side effects were comparable to those from other Covid-19 vaccines, but it has not yet published the data in a peer-reviewed scientific journal.
The Indian drug regulator approved the two-dose vaccine, which comes in the form of nasal drops, for adults who have not had a previous Covid-19 shot, Bharat Biotech said. The company has the right to sell it in India and most of the rest of Asia and Africa.
Elsewhere, the Coalition for Epidemic Preparedness Innovations, a global partnership financing vaccine development for epidemic threats, is developing a plan for nasal vaccine research projects.
For example, we are looking into whether nasal vaccines could be an option for our all-in-one coronavirus vaccine program funding the development of vaccines against both Covid-19 variants and other coronaviruses, said Melanie Saville, CEPIs executive director of vaccine research and development.
CEPI awarded nearly $5 million in seed funding to the Dutch company Intravacc for a nasal vaccine candidate that could work against multiple coronaviruses.
There are now 95 nasal vaccines under development around the world, according to health data company Airfinity. Six have reached the final Phase 3 in clinical trials.
But some scientists doubt that a nasal vaccine will be a game-changer.
William Haseltine, a former professor at Harvard Medical School with expertise in HIV/AIDS and genomics, believes that enthusiasm should be tempered about the potential of nasal vaccines to prevent infection, given that natural nasal exposure to the virus doesnt prevent people from getting reinfected.
Why in the world do you think that if you [spray] a vaccine up the nose you can do any better? he asked POLITICO.
Attempts to develop a nasal version of the AstraZeneca Covid-19 vaccine, the injectable version of which was widely used globally at the beginning of the vaccination campaign, experienced a setback after only a minority of participants in an early stage clinical trial showed some immune response in respiratory mucous membranes.
Haseltine argued that scientists still dont have a good understanding of nasal immunity and that government funding would be better directed to antiviral drugs that keep Covid-19 in check.
And Bok doesnt think any of the existing non-injectable vaccines stop Covid-19 transmission. I would be very surprised if India or China licensed it with data proving that an intranasal vaccine is better than the ones we have, she said.
Curiel and Diamond have licensed their vaccine for potential use in the U.S. to Pennsylvania-based biotech Ocugen.
The company is looking for both regulatory and financial support from the U.S. government to develop the vaccine as a booster, CEO Shankar Musunuri told POLITICO.
But without another Operation Warp Speed, there will be substantial delays in large-scale manufacturing, regulatory approval and distribution of a nasal vaccine, argued Topol and Iwasaki.
Iwasaki, who is working to develop a booster Covid-19 nasal vaccine, said she will probably need tens of millions of dollars to test it in clinical trials. Just trying to do this as a small academic lab is very different from a Warp Speed, she told POLITICO.
Thats unlikely to happen.
Congress last month passed a short-term measure to continue funding the government until Dec. 16 without any additional money for Covid-19. The White House had asked for $8 billion to fund the next generation of vaccines and therapeutics, including nasal vaccines.
There is no plan B: If Congress does not fund this, it will not happen, Jha said. America will fall further behind China and other countries.
Follow this link:
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line - POLITICO
- 2024 CDC COVID-19 guidelines: Isolation, masks, what you should know - The Arizona Republic - February 29th, 2024 [February 29th, 2024]
- Long Covid and Impaired Cognition More Evidence and More Work to Do | NEJM - nejm.org - February 29th, 2024 [February 29th, 2024]
- Prospective Memory Assessment before and after Covid-19 | NEJM - nejm.org - February 29th, 2024 [February 29th, 2024]
- A pandemic that won't go away as COVID enters its 5th year, NZ needs a realistic strategy - The Conversation - February 29th, 2024 [February 29th, 2024]
- Older US adults should get another COVID-19 shot, advisers say - Detroit News - February 29th, 2024 [February 29th, 2024]
- Vaping increases susceptibility to COVID-19 infection, study finds - News-Medical.Net - February 29th, 2024 [February 29th, 2024]
- Older U.S. adults should get another covid-19 shot, advisers say - TribLIVE - February 29th, 2024 [February 29th, 2024]
- Vapers More Susceptible to COVID-19 Infection Than Tobacco Smokers, Reveals Study | Weather.com - The Weather Channel - February 29th, 2024 [February 29th, 2024]
- How we met: She was in the next hospital bed and I loved her accent - The Guardian - February 29th, 2024 [February 29th, 2024]
- Fleet To Hit Record Size In 2024 But Still Suffering Covid Hangover - Forbes - February 29th, 2024 [February 29th, 2024]
- How vaccine hesitancy is contributing to rising rates of measles and COVID - PBS NewsHour - February 29th, 2024 [February 29th, 2024]
- How did COVID-19 impact cancer incidence trends in the US? - News-Medical.Net - February 29th, 2024 [February 29th, 2024]
- CT-based Assessment at 6-Month Follow-up of COVID-19 Pneumonia patients in China | Scientific Reports - Nature.com - February 29th, 2024 [February 29th, 2024]
- Covid in 2024: What to Know About Guidelines, Symptoms and Vaccines - WSJ - The Wall Street Journal - February 29th, 2024 [February 29th, 2024]
- Unlocking coronavirus structure through M protein research - News-Medical.Net - February 29th, 2024 [February 29th, 2024]
- SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
- People 65 and up should now get another COVID-19 vaccine, CDC recommends - cleveland.com - February 29th, 2024 [February 29th, 2024]
- Welcome to the 2024 CFA Annual Report | Covid-19 | news-journal.com - Longview News-Journal - February 29th, 2024 [February 29th, 2024]
- Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national ... - Nature.com - February 29th, 2024 [February 29th, 2024]
- R.I. COVID-19 cases increased by 337 last week, with 2 deaths - Providence Business News - February 29th, 2024 [February 29th, 2024]
- Older US adults should get another COVID-19 shot, advisers say - NBC Bay Area - February 29th, 2024 [February 29th, 2024]
- Cognitive Deficits Seen in COVID-19 Patients Regardless of Symptom Duration - HealthDay - February 29th, 2024 [February 29th, 2024]
- CDC recommends seniors get another Covid-19 shot - Baltimore Sun - February 29th, 2024 [February 29th, 2024]
- Odds of Severe COVID-19 High for Hematologic Cancer Patients During Pandemic - HealthDay - February 29th, 2024 [February 29th, 2024]
- COVID-19 may have small but lasting effects on cognition and memory | Imperial News - Imperial College London - February 29th, 2024 [February 29th, 2024]
- More free home COVID-19 tests available from US government - WCVB Boston - November 20th, 2023 [November 20th, 2023]
- Seniors made up 63 percent of covid hospitalizations earlier this year - The Washington Post - November 20th, 2023 [November 20th, 2023]
- Fifth Covid-19 wave sees biggest bump in virus detection since ... - New Zealand Herald - November 20th, 2023 [November 20th, 2023]
- KFF COVID-19 Vaccine Monitor November 2023: With COVID ... - KFF - November 20th, 2023 [November 20th, 2023]
- What to Know About the New Dominant Covid Variant - The New York Times - August 12th, 2023 [August 12th, 2023]
- Should You Get Another Covid Booster Now, or Wait Until the Fall? - The New York Times - August 12th, 2023 [August 12th, 2023]
- A 'mini cyclone' helps detect coronavirus in the air - Science News Explores - August 12th, 2023 [August 12th, 2023]
- Infection prevention and control in the context of coronavirus ... - World Health Organization - August 12th, 2023 [August 12th, 2023]
- Serum ferritin level during hospitalization is associated with Brain ... - Nature.com - August 12th, 2023 [August 12th, 2023]
- Rhode Island Man Sentenced to Three Years in Prison for Theft and ... - Department of Justice - August 12th, 2023 [August 12th, 2023]
- Posts Exaggerate Significance of Swiss Study on Heart Risk and ... - FactCheck.org - August 12th, 2023 [August 12th, 2023]
- Wenstrup Presses Department of Education for Answers on Misuse ... - House Committee on Oversight and Reform | - August 12th, 2023 [August 12th, 2023]
- Biden Administration Fails to Share Intel on COVID-19 Origins, but Independent Evidence Is Piling Up - Heritage.org - June 24th, 2023 [June 24th, 2023]
- Do I need a booster vaccine if I recently had COVID? What if I'm not sure what I had? - The Conversation - June 24th, 2023 [June 24th, 2023]
- Psychics, wrestlers and churches: How online shopping and Covid changed mall tenants - Buffalo News - June 24th, 2023 [June 24th, 2023]
- Report: Incarcerated populations up 4% post-COVID - CorrectionsOne - June 24th, 2023 [June 24th, 2023]
- The National Average for Gross Revenue at ECP Locations Decreased for the Week of June 12 18, Jobson's Latest ... - Vision Monday - June 24th, 2023 [June 24th, 2023]
- ODNI Releases Report on the Potential Links Between the Wuhan ... - Office of the Director of National Intelligence - June 24th, 2023 [June 24th, 2023]
- U.S. Intelligence Agencies May Never Find Covid's Origins, Officials ... - The New York Times - June 24th, 2023 [June 24th, 2023]
- Covid-19 likely came from lab leak, says news report citing US energy ... - March 4th, 2023 [March 4th, 2023]
- Classified Energy Department report finds lab leak likely cause of ... - March 4th, 2023 [March 4th, 2023]
- Mayor Kirk Watson tests positive for COVID-19 - KEYE TV CBS Austin - February 5th, 2023 [February 5th, 2023]
- Biden's plan for ending the emergency declaration for COVID-19 signals a pivotal point in the pandemic 4 questions answered - The Conversation... - February 5th, 2023 [February 5th, 2023]
- Study finds one habit can significantly lower your odds of getting sick from COVID-19 - KATU - February 5th, 2023 [February 5th, 2023]
- How will life change once the COVID-19 emergency ends? - KFOX El Paso - February 5th, 2023 [February 5th, 2023]
- Shipping Corporation of India and Seven Islands Shipping re-join membership of INSA - ETInfra.com - January 30th, 2023 [January 30th, 2023]
- COVID-19 Response | United Nations - December 28th, 2022 [December 28th, 2022]
- Top German virologist says COVID-19 pandemic is over - Hindustan Times - December 28th, 2022 [December 28th, 2022]
- China says impossible to track COVID spread as virus surges - Al Jazeera English - December 14th, 2022 [December 14th, 2022]
- What are the most common COVID symptoms now? Its no longer fever, loss of taste - AL.com - December 14th, 2022 [December 14th, 2022]
- Entropy and life - Wikipedia - November 27th, 2022 [November 27th, 2022]
- Negentropy - Wikipedia - November 27th, 2022 [November 27th, 2022]
- Coronavirus: OC reported 1,602 new cases and six more deaths over the past week, as of Nov. 17 - OCRegister - November 19th, 2022 [November 19th, 2022]
- How COVID-19 damages lungs: The virus attacks mitochondria, continuing an ancient battle that began in the primordial soup - The Conversation - October 30th, 2022 [October 30th, 2022]
- How to save this winter on heating costs - WKYC.com - October 23rd, 2022 [October 23rd, 2022]
- 'Fonseca' book review: The Goan artist's biography misses the art of the matter - The New Indian Express - October 23rd, 2022 [October 23rd, 2022]
- Researchers' tests of lab-made version of Covid virus draw scrutiny - STAT - October 21st, 2022 [October 21st, 2022]
- Coronavirus: Orange County reported 1,427 more cases and seven more deaths in the past week as of Oct. 20 - OCRegister - October 21st, 2022 [October 21st, 2022]
- 3 Illinois Counties at High Community Level for COVID-19 as 1 Million Bivalent Booster Shots Have Been Administered - NBC Chicago - October 21st, 2022 [October 21st, 2022]
- What Is Coronavirus? | Johns Hopkins Medicine - October 17th, 2022 [October 17th, 2022]
- Gaston County reported 177 additional COVID-19 cases this week - Gaston Gazette - October 17th, 2022 [October 17th, 2022]
- Coronavirus Roundup: The Biden Administration Renews the Public Health Emergency for COVID-19 - GovExec.com - October 17th, 2022 [October 17th, 2022]
- Circulation of Public Warning Alert on COVID-19 vaccines fraudulently using PAHO's name and logo - World - ReliefWeb - October 17th, 2022 [October 17th, 2022]
- Time to Get Your Flu Shot and Your COVID-19 Booster Too - Health.mil - October 17th, 2022 [October 17th, 2022]
- Evasive COVID-19 subvariants that you dont know about are spreading fast - Poynter - October 17th, 2022 [October 17th, 2022]
- Deer and mink can harbor Covid-19: Why animal virologists say we need to worry - Inverse - October 17th, 2022 [October 17th, 2022]
- Europe likely entering another COVID wave, says WHO and ECDC - Reuters - October 17th, 2022 [October 17th, 2022]
- COVID-19 Daily Update 10-17-2022 - West Virginia Department of Health and Human Resources - October 17th, 2022 [October 17th, 2022]
- Coronavirus: Government seeking to extend powers behind COVID restrictions until 2025 - Newshub - October 17th, 2022 [October 17th, 2022]
- Shocking: EcoHealth Alliance receives another round of funding for coronavirus bat research in Asia - The Center Square - October 17th, 2022 [October 17th, 2022]
- Opportunities in Health Education in the Post-COVID-19 Era: Transforming Viral to Vital - Cureus - October 17th, 2022 [October 17th, 2022]
- Fauci says COVID-19 was politicized by triple whammy of outbreak, division and 2020 election - WJTV - October 17th, 2022 [October 17th, 2022]
- How long does immunity from the new COVID bivalent boosters last 'in the real world'? - San Francisco Chronicle - October 17th, 2022 [October 17th, 2022]
- Respiratory illnesses have spiked among children. Here's what parents need to know. - Yahoo News - October 17th, 2022 [October 17th, 2022]
- Coronavirus Today: Who's dying of COVID-19 now? - Los Angeles Times - September 22nd, 2022 [September 22nd, 2022]